BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34542753)

  • 21. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival.
    Kornblau SM; Ruvolo PP; Wang RY; Battula VL; Shpall EJ; Ruvolo VR; McQueen T; Qui Y; Zeng Z; Pierce S; Jacamo R; Yoo SY; Le PM; Sun J; Hail N; Konopleva M; Andreeff M
    Haematologica; 2018 May; 103(5):810-821. PubMed ID: 29545342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant.
    Carrara RC; Orellana MD; Fontes AM; Palma PV; Kashima S; Mendes MR; Coutinho MA; Voltarelli JC; Covas DT
    Braz J Med Biol Res; 2007 Jan; 40(1):57-67. PubMed ID: 17224997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia.
    Zhao Z; Tang X; You Y; Li W; Liu F; Zou P
    Leuk Res; 2006 Aug; 30(8):993-1003. PubMed ID: 16448696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biogenesis of Mitochondria in Multipotent Mesenchymal Stromal Cells in Patients with Acute Leukemia.
    Sadovskaya AV; Petinati NA; Sats NV; Drize NI; Vasil'eva AN; Aleshina OA; Parovichnikova EN
    Bull Exp Biol Med; 2023 Dec; 176(2):283-289. PubMed ID: 38194072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemia-Induced Cellular Senescence and Stemness Alterations in Mesenchymal Stem Cells Are Reversible upon Withdrawal of B-Cell Acute Lymphoblastic Leukemia Cells.
    Vanegas NP; Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
    Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
    Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow mesenchymal stem cells for improving hematopoietic function: an in vitro and in vivo model. Part 2: Effect on bone marrow microenvironment.
    Carrancio S; Blanco B; Romo C; Muntion S; Lopez-Holgado N; Blanco JF; Briñon JG; San Miguel JF; Sanchez-Guijo FM; del Cañizo MC
    PLoS One; 2011; 6(10):e26241. PubMed ID: 22028841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stanniocalcin 1 is overexpressed in multipotent mesenchymal stromal cells from acute myeloid leukemia patients.
    Schelker RC; Kratzer A; Müller G; Brochhausen C; Hart C; Stempfl T; Heudobler D; Moehle C; Herr W; Iberl S; Grassinger J
    Hematology; 2021 Dec; 26(1):565-576. PubMed ID: 34384344
    [No Abstract]   [Full Text] [Related]  

  • 30. Stromal abnormalities in neoplastic bone marrow diseases.
    Dührsen U; Hossfeld DK
    Ann Hematol; 1996 Aug; 73(2):53-70. PubMed ID: 8774614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
    Bhatia R; McGlave PB; Dewald GW; Blazar BR; Verfaillie CM
    Blood; 1995 Jun; 85(12):3636-45. PubMed ID: 7780147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
    Winfield DA; Polacarz SV
    J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis.
    Vianello F; Villanova F; Tisato V; Lymperi S; Ho KK; Gomes AR; Marin D; Bonnet D; Apperley J; Lam EW; Dazzi F
    Haematologica; 2010 Jul; 95(7):1081-9. PubMed ID: 20179085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells.
    Yehudai-Resheff S; Attias-Turgeman S; Sabbah R; Gabay T; Musallam R; Fridman-Dror A; Zuckerman T
    Int J Cancer; 2019 May; 144(9):2279-2289. PubMed ID: 30548585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Khandanpour C; Cadeddu RP; Gutekunst J; Wilk CM; Fenk R; Zilkens C; Hermsen D; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Leukemia; 2016 Mar; 30(3):683-91. PubMed ID: 26601782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
    Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
    Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematon: a multicellular functional unit in primary hematopoiesis.
    Blazsek I; Misset JL; Comisso M; Mathé G
    Biomed Pharmacother; 1988; 42(10):661-8. PubMed ID: 3266080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
    Park M; Park CJ; Cho YW; Jang S; Lee JH; Lee JH; Lee KH; Lee YH
    Exp Hematol; 2017 Jan; 45():56-63. PubMed ID: 27693387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies.
    el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
    Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone Marrow Multipotent Mesenchymal Stromal Cells from Patients with Aplastic Anemia Retain Their Ability to Support Hematopoietic Precursors despite Pronounced Changes in Gene Expression.
    Dorofeeva AI; Shipunova IN; Drize NI; Luchkin AV; Abramova AV; Fidarova ZT; Dvirnyk VN; Gal'tseva IV; Mikhailova EA; Parovichnikova EN
    Bull Exp Biol Med; 2022 Mar; 172(5):637-641. PubMed ID: 35352257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.